177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer

Phase I/II Trial of R-CHOP + Azacytidine in Diffuse Large B Cell Lymphoma

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

A Safety Study of SGN-LIV1A in Breast Cancer Patients

Proof of Concept Study of an Oral Orthotic to Reduce Tic Severity in Chronic Tic Disorder and Tourette Syndrome

3 Dimensional Sonography Imaging

Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease

Choledochoscopy Multicenter Registry

Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis

Stress Level and the Relationship With IVF Outcomes.

The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study

BAX 855 Previously Untreated Patient (PUP)

Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC

Study Evaluating Safety and Efficacy of UCART123 in Patients With Acute Myeloid Leukemia

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera

Phase I Trial of 225Ac−J591 in Patients With mCRPC

Pulmonary Fibrosis Foundation Patient Registry

A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis

First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)

Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

Study of 5-azacitidine in Combination With Vorinostat in Patients With Relapsed or Refractory Diffuse Large b Cell Lymphoma (DLBCL)

Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)

T-EUS for Gastrointestinal Disorders: A Multicenter Registry

Endothelial Microparticles as a Biomarker for Diagnosis and Prognosis in Early Sepsis

Connect® MDS/AML Disease Registry

Bendamustine Bridge to Autologous or Allogeneic Transplant for Relapsed/Refractory Lymphoma

Safety Study of Anti-LAG-3 in Relapsed or Refractory Hematologic Malignancies

Peroral Endoscopic Myotomy (POEM) For The Treatment Of Achalasia: A Registry

Stem Cell Monitoring for CML Patients Undergoing Nilotinib Therapy

KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma

Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR

IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia

A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)

An Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia

Study of the Safety, Tolerability and Efficacy of KPT-8602 in Patients With Relapsed/Refractory Cancer Indications

Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)

Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

Proof-of-concept Study to Assess the Efficacy and Safety of SRX246 in Adults With PTSD

An Efficacy and Safety Study of SHP647 as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis

A Study of Enfortumab Vedotin Plus Pembrolizumab and/or Chemotherapy for Patients With Urothelial Bladder Cancer (EV-103)

A Study to Evaluate Safety, Pharmacokinetics, and Clinical Activity of Combination of RO6870810 and Venetoclax, With or Without Rituximab, in Participants With Relapsed/Refractory DLBCL and/or High-Grade B-Cell Lymphoma and/or High Grade B-Cell Lymphoma With MYC and/or BCL2 and/or BCL6

Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Open-Label Study to Evaluate Efficacy and Safety of SCY-078 in Patients With Refractory or Intolerant Fungal Diseases

CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome

A Study of LAM-003 in Patients With Acute Myeloid Leukemia

Efficacy and Safety of AbGn-168H in Patients With Moderate to Severe Active, Anti-TNF Alpha and/or Anti-integrin Refractory Ulcerative Colitis

A Study to Assess the Antitumor Activity, Safety, Pharmacokinetics and Biomarkers of Zolbetuximab (IMAB362) in Participants With Claudin (CLDN) 18.2 Positive, Metastatic or Advanced Unresectable Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma

An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant

Phase II Palbociclib +Ibrutinib in Mantle Cell Lymphoma

Imaginal Exposure & D-Cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD)

Analysis of Donor Biopsy Tissue Samples at the Time of Kidney Transplant

Lenalidomide Plus Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Phase 1 / 2 Study

177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors

Dose Response of Functionally Critical Brain Regions for Brain Radiotherapy

Emotional and Cognitive Control in Late-Onset Depression

Study of Acalabrutinib Alone or in Combination Therapy in Subjects With B-cell Non-Hodgkin Lymphoma

CD19 CART Long Term Follow Up (LTFU) Study

A Phase 1 Study to Investigate the Safety and Tolerability of REGN1979 in Patients With CD20+ B-Cell Malignancies

Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis

Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MS

A Study of Venetoclax in Combination With Cobimetinib and Venetoclax in Combination With Idasanutlin in Patients Aged >/= 60 Years With Relapsed or Refractory Acute Myeloid Leukemia Who Are Not Eligible for Cytotoxic Therapy

Depression, Obesity and Inflammatory Markers

Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis

STRIDE Biorepository

Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis

A Study to Evaluate the Effect of Vitamin D on PFS in Indolent Non-Hodgkin's Lymphoma

Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast Cancer

177Lu−J591 and 177Lu−PSMA−617 Combination for mCRPC

A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Erdafitinib Plus JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Metastatic or Surgically Unresectable Urothelial Cancer With Selected FGFR Gene Alterations

Study of AAVrh10-h.SGSH Gene Therapy in Patients With Mucopolysaccharidosis Type IIIA (MPS IIIA)

The Efficacy and Safety of UGN-102 as a Primary Chemoablation Therapy in Patients With LG NMIBC at Intermediate Risk of Recurrence

Direct Acting Antiviral-Post Authorization Safety Study

Use of Semen TEX101 to Improve Sperm Retrieval Rates for Men With Non-obstructive Azoospermia

The Effects of Potassium Citrate on Bone Metabolism

RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF

Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma

FemVue and Tubal Patency

Effects of Electronic Cigarettes on Lung Biology

Changes Associated With H. Pylori and Gastric Carcinogenesis

Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry

Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab

Intervention Using Vitamin D for Elevated Urinary Albumin Treated With Losartan in Diabetes (IDEAL)

Integrative-omics of the Disordered COPD Small Airway Epithelium

Expanded Access Protocol for Tabelecleucel in Subjects With EBV-Associated Viremia or Malignancies

Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis

Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)

High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies

First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas

A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

Middle Meningeal Artery Embolization for Treatment of Chronic Subdural Hematoma

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04

AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH

Trial to Compare Radiation Fibrosis With Five Versus Three Fractions